New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

AI is transforming oncology by improving early detection, diagnosis, and treatment personalization through advanced data ...

Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.

Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality. This is particularly pronounced in low-resource settings ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in ...

mCRC treatment involves balancing efficacy, tolerability, and patient goals, with fruquintinib, regorafenib, and trifluridine-tipiracil as key therapies. Oncology pharmacists are essential in ...

Please provide your email address to receive an email when new articles are posted on . Shared decision-making and survivorship were two areas of emphasis in the ATA’s 2025 thyroid cancer guideline.

Cancer cachexia is a complex metabolic syndrome characterized by the ongoing loss of skeletal muscle mass, with or without fat loss, that cannot be reversed entirely by conventional nutritional ...

Misusing the words cancer and tumour can be confusing and misleading. This may be because the word "cancer" carries a stigma ...